Merck Settles Fosamax Jaw-Injury Claims For $28M
Resolving long-running multidistrict litigation in New York, Merck & Co. Inc. agreed Monday to pay $27.7 million to settle hundreds of lawsuits claiming its bone drug Fosamax caused a condition known...To view the full article, register now.
Already a subscriber? Click here to view full article